| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509186A Composition containing epigallocatechin gallate |
| 06/30/2004 | CN1509180A Method for treating syndrome X with aliphatic polyamines |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509173A Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 06/30/2004 | CN1509169A Use of enantiomeric pure escitalopram |
| 06/30/2004 | CN1509162A Cosmetics |
| 06/30/2004 | CN1508542A Ginkgo leaf composition, and preparing method and use thereof |
| 06/30/2004 | CN1508131A Ferrous orotic acid, and preparing method and use thereof |
| 06/30/2004 | CN1507917A Medicine containing nitric oxide synthase inhibitor for treating diabetes |
| 06/30/2004 | CN1507903A Health-care product for antilipemic and preventing cardio-cerebrovascular disease |
| 06/30/2004 | CN1507876A Medicine 'kelaoning' for preventing and treating diabete |
| 06/30/2004 | CN1507871A Use of phytanic acid for treating diabetes |
| 06/30/2004 | CN1507865A Diabetes medicine containing tri pyridine chromium formate |
| 06/30/2004 | CN1507863A Use of aza cyclopentane dione derivative for treating diabetes |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155586C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/30/2004 | CN1155406C Nitrogen oxide generation inhibitor |
| 06/30/2004 | CN1155405C Recipe and prepn. of medicine for treating diabetic ulcer and preparation method |
| 06/30/2004 | CN1155394C Microcapsule coated trace element product and its producing method |
| 06/30/2004 | CN1155375C Linolic acid and linolenic acid capsule and its making process |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756393 Amides and ureas n-substituted with piperidine or nortropane; serotonin inverse agonists or antagonists; antipsychotic |
| 06/29/2004 | US6756388 Having piperidinyl and phenolic functionality; bone loss; breast or prostate cancer |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756364 Method of reducing gastrointestinal side effects associated with orlistat treatment |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756065 Anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/29/2004 | CA2296726C Combination therapy |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/29/2004 | CA2205384C Dihydropyrimidines and uses thereof |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/29/2004 | CA2131002C Effect of particle-size distribution of cellulose ethers on palatability of compositions |
| 06/24/2004 | WO2004053124A1 Method of screening remedy or preventive for diabetes |
| 06/24/2004 | WO2004052903A1 Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052902A1 Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 06/24/2004 | WO2004052876A1 Substituted 4-phenyl-[1,3]-dioxanes |
| 06/24/2004 | WO2004052869A1 5-substituted-pyrazine or pyridine glucokinase activators |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052862A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 06/24/2004 | WO2004052848A1 Novel mch receptor antagonists |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052385A1 Composition containing green and yellow vegetables and light-colored vegetables |
| 06/24/2004 | WO2004052382A1 A kind of chinese traditional medicine having efficacy of reducing blood-fat |
| 06/24/2004 | WO2004052380A1 Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same |
| 06/24/2004 | WO2004052368A1 Use of certain compounds in treatment of obesity |
| 06/24/2004 | WO2004052286A2 Tyrosine kinase inhibitors |
| 06/24/2004 | WO2004052123A1 Zinc-rich foods having effect of preventing diabetes |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2004010953A3 Implantable artificial organ devices |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003072056A3 Intranasal administration of mc4-r agonists |
| 06/24/2004 | WO2003057200A3 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003049686A3 Stabilization of hypoxia inducible factor (hif) alpha |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | US20040122235 such as N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; for treating diseases in which increasing glucokinase activity is beneficial (diabetes) |
| 06/24/2004 | US20040122165 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 06/24/2004 | US20040122094 Isomers of conjugated linoleic acids at either the 1 and 3 or 2 positions of the acylglyceride molecule and another fatty acyl residue at the other of 1 and 3 OR 2 positions of acylglyceride molecule; useful as dietary supplements |
| 06/24/2004 | US20040122076 The use of 1-(iso)indolylsulfonamido-),4-(alkylamido-)benzenes and derivatives as 5-Ht6receptor antagonists; Alzheimer's disease; neurodegenerative diseases; prophylaxis |
| 06/24/2004 | US20040122044 Utilization of substituted imidazo [1,2-A]-pyridin-3-yl-amide and imidazo [1,2-A]-pyridin-3-yl-amine compounds in pharmaceutical formulations |
| 06/24/2004 | US20040122040 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 06/24/2004 | US20040122039 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 06/24/2004 | US20040122038 phenanthridin derivative containing amine or amide groups; useful for treating obesity, a feeding disorder, seizures, anxiety, diabetes, hypertension, hyperlipidemia, cancer, nasal congestion, and female or male sexual dysfunction |
| 06/24/2004 | US20040122037 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 06/24/2004 | US20040122031 Thiazolidinedione and pharmaceutical composition comprising the same |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122017 Melanin concentrating hormone (MCH) modulators; metabolic and eating disorders |
| 06/24/2004 | US20040122010 Treatment of neuropathy |
| 06/24/2004 | US20040122006 such as 7-[(2-aminophenyl)sulfanyl]-2H-1,4-benzoxazin-3(4H)-one; oxidation/reduction; deblocking/deprotectiing; cardiovascular disorders |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | US20040122001 Pharmaceutical compounds |
| 06/24/2004 | US20040121993 for the reduction of cholesterol in blood, and treatment of fatty liver, hyperglycemia and diabetes |
| 06/24/2004 | US20040121979 Pharmaceutically active uridine esters |
| 06/24/2004 | US20040121962 Prodrugs of excitatory amino acids |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121460 Pancreatic tissue culture prepared from embryonic stem cells for treatment of panreactic and diabetic disorders |
| 06/24/2004 | US20040121443 Modified protamine with reduced immunogenicity |
| 06/24/2004 | US20040121395 Sequence #115 as a target for identifying weight modulating compounds |
| 06/24/2004 | US20040121372 Comprises receptors for advanced glycation endproduct polypeptides for use in diagnosis and treatment inflammation, infection, sepsis, autoimmune, atherosclerotic and nervous system disorders |
| 06/24/2004 | US20040121327 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 06/24/2004 | US20040121028 Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticals |
| 06/24/2004 | US20040120984 Compositions comprising dietary fat complexer and methods for their use |
| 06/24/2004 | US20040120963 bacteria belongs to the genus Megasphaera or Mitsuokella |
| 06/24/2004 | US20040120940 Placental alkaline phosphatase to control diabetes |
| 06/24/2004 | US20040120936 Enhanced composition for treatment of obesity |
| 06/24/2004 | CA2509042A1 Novel mch receptor antagonists |
| 06/24/2004 | CA2507987A1 A vegetable composition having blood enhancing properties |
| 06/23/2004 | EP1431294A1 Vascular wall-selective acat inhibitor |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |